Skip to site menu Skip to page content

Daily Newsletter

28 August 2023

Daily Newsletter

28 August 2023

NextGen and Luma Health partner on AI-based patient engagement tech

Using the tools, patients can interact with staff, submit documents, and confirm or cancel appointments.

Satarupa Bhowmik August 25 2023

Healthtech firm NextGen Healthcare has expanded its collaboration with Luma Health to offer artificial intelligence (AI)-enhanced patient communication tools to ambulatory organisations across the US.

The partnership sees the integration of Luma-powered NextGen Patient Engage and NextGen Self-Scheduling into NextGen Enterprise electronic health records (EHR).

Patients can access these tools using their mobile devices to communicate with their health providers in over 20 languages.

Using the technologies, patients can interact with staff, complete pre-visit intake forms, submit documents, and confirm or cancel appointments.

For customers of NextGen Healthcare, they will be able to carry out surveys, send appointment reminders, offer new service lines, as well invite patients to join the ‘smart’ waitlist for quick appointments in tune with their current appointment type.

In addition, staff burden is reduced with automated conversational responses to patient texts, leveraging natural language processing and AI.

Luma chief technology officer and co-founder Aditya Bansod said: “We’re thrilled to enter this strategic alliance to bring the power of Luma’s comprehensive Patient Success Platform to NextGen Healthcare’s extensive client bases.

“Luma’s market-leading capabilities natively integrated with award-winning NextGen Enterprise will help patients and providers partner together and will create scalable patient, staff, and system success.” 

Currently, Luma caters to over 600 health systems, speciality networks, clinics, integrated delivery networks, and federally qualified health centres, along with speciality networks in the US.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close